SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ARRIS - Another partner
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
353 2 0 AXPH
Emcee:  Paul Getman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
153 Max, thank for data on article. I do not have subscription for Science, and caMiljenko Zuanic-9/22/1997
152 Miljenko, interesting little article in the 12-sept issue of Science (page 1602Pseudo Biologist-9/21/1997
151 Partial list from Tryptase/inflammation MEDLINE search: Tetlow LC , et al; DiMiljenko Zuanic-7/20/1997
150 Max, James, Cyberken, and others: Second amendment to contract, in short time Miljenko Zuanic-7/20/1997
149 George; US biotech stocks are generally quite a bit cheaper than UK biotech stoDavid Bogdanoff-7/20/1997
148 Minor mention of Arris in this weeks Economist. Please see my latest post on Caknahow-7/20/1997
147 James, you are right; the puzzle is why they bother to continue work on APC 366Pseudo Biologist-7/20/1997
146 Kenny, Bayer is pursuing two separate asthma projects with ARRS because one isJames Silverman-7/19/1997
145 As your post demonstrates, this complex announcement opens many more questions CYBERKEN-7/19/1997
144 Miljenko, you are welcome. At least we can try to revive this thread for a whiPseudo Biologist-7/18/1997
143 Max, Thanks very much for you view. Mostly I agree with you, but I do have sevMiljenko Zuanic-7/18/1997
142 Miljenko, as promised in the Isis thread I am taking a shot at this release. IPseudo Biologist-7/18/1997
141 CYBERKEN; Please share with use your reasoning on your predicted advance in biDavid Bogdanoff-7/15/1997
140 I'm actually suprised that this stock doesn't get many comments on the CYBERKEN-7/15/1997
139 To all: Nobody care for today announcement? businesswire.com mzMiljenko Zuanic-7/14/1997
138 MIchael-I am a long time subscriber and recently bought some H & Q Lifesciebob s-7/6/1997
137 Probably, my reaction was premature. CNSI was, and still is, very cheep and I wMiljenko Zuanic-6/27/1997
136 Arris was up >$1 this AM on the news. Perhaps the street is noticing the oveCYBERKEN-6/26/1997
135 David, First let me say: Reason that I sold ARRS does not have to do anything Miljenko Zuanic-6/25/1997
134 MZ: Thanks for the arrs info. With p<= .05, we have statistical signficanceDavid Bogdanoff-6/25/1997
133 To all: Today Arris report preliminary results on first PIIa APC-366 trials: Miljenko Zuanic-6/25/1997
132 Max, Thanks for the link to article. John, Mast cells secrete several tryptasMiljenko Zuanic-6/21/1997
131 Thanks for the link, Miljenko. This is new information for me. APC366 is the John Metcalf-6/20/1997
130 Miljenko, I have no opinion but if you want to read the whole article try jci.oPseudo Biologist-6/20/1997
129 John, What is your opinion on Reuters news: reutershealth.com Rule of the trMiljenko Zuanic-6/20/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News